🇺🇸 MT-6548 in United States

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

FDA authorised MT-6548 on 27 March 2024

Marketing authorisation

FDA — authorised 27 March 2024

Application: NDA215192
Marketing authorisation holder: AKEBIA
Local brand name: VAFSEO
Indication: TABLET — ORAL
Status: approved

Read official source →

Frequently asked questions

Is MT-6548 approved in United States?

Yes. FDA authorised it on 27 March 2024.

Who is the marketing authorisation holder for MT-6548 in United States?

AKEBIA holds the US marketing authorisation.